Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.
about
Isoniazid metabolism and hepatotoxicityA discriminative analytical method for detection of CES1A1 and CES1A2/CES1A3 genetic variantsPharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsIndividualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Carboxylesterase 1 gene duplication and mRNA expression in adipose tissue are linked to obesity and metabolic functionPharmacogenomics of antimicrobial agents.In vivo space radiation-induced non-targeted responses: late effects on molecular signaling in mitochondria.Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.Carboxylesterases in lipid metabolism: from mouse to human.Relationship between CES2 genetic variations and rifampicin metabolism.Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1.Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.Clinical implications of genetic variation in carboxylesterase drug metabolism.
P2860
Q28076859-0E7C961B-9F8F-479E-A8FB-8754C9049C14Q28257265-FCE89C3B-708F-4A88-9592-FD37F79EE59EQ28554328-F2237265-B77D-4252-9D68-ACEAE98FDDA4Q30373969-28D156F9-BDC5-41CE-AE75-D21743BF807EQ34611588-51B40534-5F80-45D3-B063-2D1805E02072Q34977413-388DDBCF-EAEA-4D51-AEB0-C892EE02217BQ35900783-ED231A4B-4E51-4B8D-B7B1-A94AB44F4153Q36767978-ABA6CECC-C736-45C9-BE6E-43FA71C8AF78Q38360770-66B3EAD9-BF84-4B30-A35D-F5193A2CBA3EQ38798449-24A36856-5CCC-4421-BCB3-F9EE57BE9F17Q38863876-08775056-DCE0-4655-A442-F1C04694F185Q39414484-A554F07D-743E-454C-B8AD-A94154D11F31Q45151120-ADE51238-BB0B-4253-A68A-2AABA1F8D190Q46155415-B2B73FE0-6042-464C-A336-56F9C42AC935Q47652000-C953FAC2-6FFB-425F-A59D-4C6D249D06CAQ47715776-40A32750-8A7D-49CD-B426-713EC3C67BBAQ47827847-096FF271-2F4A-46C7-B559-C6CC1ACAFC2AQ48061495-5E910FDD-0C5E-4512-834A-9D921EE7436DQ49487192-29639C15-19F2-47B5-9F1C-2B8009EF15F6Q49628042-A07D7666-D36B-44C0-A6AB-89AC5CBABC06
P2860
Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@en
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@nl
type
label
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@en
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@nl
prefLabel
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@en
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@nl
P2093
P2860
P356
P1476
Genetic variation in carboxyle ...... niazid-induced hepatotoxicity.
@en
P2093
A Brooks-Wilson
J Halaschek-Wiener
J M Fitzgerald
K Richardson
P2860
P2888
P304
P356
10.1038/TPJ.2010.5
P577
2010-03-02T00:00:00Z